Your browser doesn't support javascript.
loading
International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Condoluci, Adalgisa; Terzi di Bergamo, Lodovico; Langerbeins, Petra; Hoechstetter, Manuela A; Herling, Carmen D; De Paoli, Lorenzo; Delgado, Julio; Rabe, Kari G; Gentile, Massimo; Doubek, Michael; Mauro, Francesca R; Chiodin, Giorgia; Mattsson, Mattias; Bahlo, Jasmin; Cutrona, Giovanna; Kotaskova, Jana; Deambrogi, Clara; Smedby, Karin E; Spina, Valeria; Bruscaggin, Alessio; Wu, Wei; Moia, Riccardo; Bianchi, Elena; Gerber, Bernhard; Zucca, Emanuele; Gillessen, Silke; Ghielmini, Michele; Cavalli, Franco; Stussi, Georg; Hess, Mark A; Baumann, Tycho S; Neri, Antonino; Ferrarini, Manlio; Rosenquist, Richard; Forconi, Francesco; Foà, Robin; Pospisilova, Sarka; Morabito, Fortunato; Stilgenbauer, Stephan; Döhner, Hartmut; Parikh, Sameer A; Wierda, William G; Montserrat, Emili; Gaidano, Gianluca; Hallek, Michael; Rossi, Davide.
Affiliation
  • Condoluci A; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Terzi di Bergamo L; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Langerbeins P; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Hoechstetter MA; Center of Integrated Oncology Cologne Bonn and German CLL Study Group, University of Cologne, Cologne, Germany.
  • Herling CD; Hospital Munich-Schwabing, German CLL Study Group, Munich, Germany.
  • De Paoli L; Center of Integrated Oncology Cologne Bonn and German CLL Study Group, University of Cologne, Cologne, Germany.
  • Delgado J; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Rabe KG; Hospital Clinic, Barcelona, Spain.
  • Gentile M; Mayo Clinic, Rochester, MN.
  • Doubek M; Azienda Ospedaliera of Cosenza, Cosenza, Italy.
  • Mauro FR; Interní Hematologická a Onkologická Klinika (IHOK), University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
  • Chiodin G; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Mattsson M; Division of Hematology, Sapienza University, Rome, Italy.
  • Bahlo J; Cancer Sciences Division, University of Southampton, Southampton, United Kingdom.
  • Cutrona G; Uppsala University Hospital, Uppsala, Sweden.
  • Kotaskova J; Center of Integrated Oncology Cologne Bonn and German CLL Study Group, University of Cologne, Cologne, Germany.
  • Deambrogi C; IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Smedby KE; Interní Hematologická a Onkologická Klinika (IHOK), University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
  • Spina V; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Bruscaggin A; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Wu W; Karolinska Institute, Stockholm, Sweden.
  • Moia R; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Bianchi E; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Gerber B; Institute of Oncology Research, Università della Svizzera Italiana, Bellinzona, Switzerland.
  • Zucca E; The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China.
  • Gillessen S; Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
  • Ghielmini M; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Cavalli F; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Stussi G; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Hess MA; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Baumann TS; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Neri A; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Ferrarini M; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Rosenquist R; University of Texas MD Anderson Cancer Center, Houston, TX.
  • Forconi F; Hospital Clinic, Barcelona, Spain.
  • Foà R; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.
  • Pospisilova S; Department of Experimental Medicine, University of Genoa, Genoa, Italy.
  • Morabito F; Karolinska Institute, Stockholm, Sweden.
  • Stilgenbauer S; Cancer Sciences Division, University of Southampton, Southampton, United Kingdom.
  • Döhner H; Southampton University Hospital Trust, Southampton, United Kingdom.
  • Parikh SA; Division of Hematology, Sapienza University, Rome, Italy.
  • Wierda WG; Interní Hematologická a Onkologická Klinika (IHOK), University Hospital Brno and Medical Faculty, Masaryk University, Brno, Czech Republic.
  • Montserrat E; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
  • Gaidano G; Biotechnology Research Unit Aprigliano, Cosenza, Italy.
  • Hallek M; Augusta Victoria Hospital, Jerusalem, Israel.
  • Rossi D; Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany; and.
Blood ; 135(21): 1859-1869, 2020 05 21.
Article in En | MEDLINE | ID: mdl-32267500

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Biomarkers, Tumor / Clinical Trials as Topic / Nomograms / Mutation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Blood Year: 2020 Type: Article Affiliation country: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Leukemia, Lymphocytic, Chronic, B-Cell / Biomarkers, Tumor / Clinical Trials as Topic / Nomograms / Mutation Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male Language: En Journal: Blood Year: 2020 Type: Article Affiliation country: Switzerland